Trial Profile
Japanese evaluation between FormuLa of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Azelnidipine (Primary) ; Olmesartan medoxomil
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms J-FLAG
- 25 Apr 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 01 Aug 2011 Design and rationale published in the Cardiovascular Drugs and Therapy.
- 19 Jan 2010 Planned number of patients changed from 500 to 250 as reported by University Hospital Medical Information Network - Japan.